Lynk Pharmaceuticals Co. Ltd. has received IND clearance from the FDA for LNK-01006, an allosteric TYK2 inhibitor with potential to treat neurodegenerative diseases.
Kanyakumari to Chhatrapati Shivaji Terminus Mumbai Kanniyakumari Mumbai CSMT Summer Special (01006), Kashi Tamil Sangamam Weekly Express (16367), Kanniyakumari Charlapalli Summer Special (07229), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results